These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 17687162)

  • 1. The fallacy of single-agent chemotherapy for cancer.
    Friedman HS; Maxwell J
    J Clin Oncol; 2007 Aug; 25(23):3550; author reply 3550-1. PubMed ID: 17687162
    [No Abstract]   [Full Text] [Related]  

  • 2. Methylguanine methyltransferase testing in glioblastoma: when and how?
    Stupp R; Hegi ME
    J Clin Oncol; 2007 Apr; 25(12):1459-60. PubMed ID: 17442986
    [No Abstract]   [Full Text] [Related]  

  • 3. Treatment of brain tumors.
    Ashby L; LaRocca R; Ryken T
    N Engl J Med; 2005 Jun; 352(22):2350-3; author reply 2350-3. PubMed ID: 15938013
    [No Abstract]   [Full Text] [Related]  

  • 4. Treatment of brain tumors.
    Seiter K
    N Engl J Med; 2005 Jun; 352(22):2350-3; author reply 2350-3. PubMed ID: 15938012
    [No Abstract]   [Full Text] [Related]  

  • 5. Chemotherapy for brain tumors--a new beginning.
    DeAngelis LM
    N Engl J Med; 2005 Mar; 352(10):1036-8. PubMed ID: 15758016
    [No Abstract]   [Full Text] [Related]  

  • 6. Correlation between O6-methylguanine-DNA methyltransferase and survival in inoperable newly diagnosed glioblastoma patients treated with neoadjuvant temozolomide.
    Chinot OL; Barrié M; Fuentes S; Eudes N; Lancelot S; Metellus P; Muracciole X; Braguer D; Ouafik L; Martin PM; Dufour H; Figarella-Branger D
    J Clin Oncol; 2007 Apr; 25(12):1470-5. PubMed ID: 17442989
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Temozolomide in patients with a glioblastoma multiforme: new developments].
    Bromberg JE; Postma TJ
    Ned Tijdschr Geneeskd; 2005 Jun; 149(25):1376-8. PubMed ID: 15997689
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic significance of O6-methylguanine-DNA methyltransferase protein expression in patients with recurrent glioblastoma treated with temozolomide.
    Nagane M; Kobayashi K; Ohnishi A; Shimizu S; Shiokawa Y
    Jpn J Clin Oncol; 2007 Dec; 37(12):897-906. PubMed ID: 18156172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term Results of a Survey of Prolonged Adjuvant Treatment with Temozolomide in Patients with Glioblastoma (SV3 Study).
    Rivoirard R; Falk AT; Chargari C; Guy JB; Mery B; Nuti C; Peoc'h M; Forest F; Garin C; Adjabi A; Hoarau D; Kawaye S; Almokhles H; Fournel P; Magné N
    Clin Oncol (R Coll Radiol); 2015 Aug; 27(8):486-7. PubMed ID: 25963856
    [No Abstract]   [Full Text] [Related]  

  • 10. Mechanisms of disease: temozolomide and glioblastoma--look to the future.
    Mrugala MM; Chamberlain MC
    Nat Clin Pract Oncol; 2008 Aug; 5(8):476-86. PubMed ID: 18542116
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictive biomarkers investigated in glioblastoma.
    Tabouret E; Chinot O; Sanson M; Loundou A; Hoang-Xuan K; Delattre JY; Idbaih A
    Expert Rev Mol Diagn; 2014 Sep; 14(7):883-93. PubMed ID: 25096963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Temozolomide for malignant brain tumours.
    Batchelor T
    Lancet; 2000 Apr; 355(9210):1115-6. PubMed ID: 10791369
    [No Abstract]   [Full Text] [Related]  

  • 13. Synergy between methionine stress and chemotherapy in the treatment of brain tumor xenografts in athymic mice.
    Kokkinakis DM; Hoffman RM; Frenkel EP; Wick JB; Han Q; Xu M; Tan Y; Schold SC
    Cancer Res; 2001 May; 61(10):4017-23. PubMed ID: 11358820
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antitumor activity of temozolomide combined with irinotecan is partly independent of O6-methylguanine-DNA methyltransferase and mismatch repair phenotypes in xenograft models.
    Houghton PJ; Stewart CF; Cheshire PJ; Richmond LB; Kirstein MN; Poquette CA; Tan M; Friedman HS; Brent TP
    Clin Cancer Res; 2000 Oct; 6(10):4110-8. PubMed ID: 11051264
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemotherapy for glioblastoma multiforme (GBM).
    Roitberg B
    Surg Neurol; 2006 Feb; 65(2):107-8. PubMed ID: 16427394
    [No Abstract]   [Full Text] [Related]  

  • 16. Solitary brain metastasis as first manifestation of small-cell parotid gland carcinoma with high sensitivity to temozolomide therapy on basis of tumor O6-methylguanine-DNA-methyltransferase expression.
    Lolli I; Morra I; Cimmino A; Trevisan E; Rudà R; Piombino M; Campanella G; Gillio Tos A; De Marco L; Trevisan M; Fiano V; Soffietti R
    J Clin Oncol; 2013 Aug; 31(23):e394-7. PubMed ID: 23796990
    [No Abstract]   [Full Text] [Related]  

  • 17. Temozolomide (Temodal) for treatment of primary brain tumours.
    MacConnachie AM
    Intensive Crit Care Nurs; 2000 Feb; 16(1):59-60. PubMed ID: 10790718
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Where does O
    Weller M
    Cancer; 2018 Apr; 124(7):1316-1318. PubMed ID: 29381186
    [No Abstract]   [Full Text] [Related]  

  • 19. [Recent advances in the medical treatment of glioma-temozolomide].
    Nishikawa R
    No To Shinkei; 2006 Dec; 58(12):1035-41. PubMed ID: 17193953
    [No Abstract]   [Full Text] [Related]  

  • 20. Down-regulation of O6-methylguanine-DNA methyl transferase enhances the effect of temozolomide in melanoma cells.
    Jiang G; Zheng JN; Liu YQ
    Med Hypotheses; 2011 Jan; 76(1):147-8. PubMed ID: 21044822
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.